Global Injectable IVF Medications Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Injectable IVF (In Vitro Fertilization) medications are pharmaceutical drugs administered via injection to stimulate and regulate a woman's reproductive system during the fertility treatment process. These medications typically include hormones such as gonadotropins and follicle-stimulating hormone (FSH), which encourage the development of multiple eggs within the ovaries. Additionally, other drugs like human chorionic gonadotropin (hCG) are used to trigger the final maturation of eggs before retrieval. Injectable IVF medications play a crucial role in controlling the ovulation process, optimizing egg production, and enhancing the chances of successful fertilization during assisted reproductive technologies.
The global Injectable IVF Medications market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Injectable IVF Medications Industry Forecast” looks at past sales and reviews total world Injectable IVF Medications sales in 2023, providing a comprehensive analysis by region and market sector of projected Injectable IVF Medications sales for 2024 through 2030. With Injectable IVF Medications sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Injectable IVF Medications industry.
This Insight Report provides a comprehensive analysis of the global Injectable IVF Medications landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Injectable IVF Medications portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Injectable IVF Medications market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Injectable IVF Medications and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Injectable IVF Medications.
The fertility preservation and infertility treatment market has witnessed significant growth in recent years, driven by factors such as increasing infertility rates, delayed pregnancies, advancements in assisted reproductive technologies (ART), and growing awareness. Fertility preservation technologies, including egg freezing and sperm banking, have gained popularity among individuals seeking to preserve their reproductive potential. In the infertility treatment segment, in vitro fertilization (IVF), intrauterine insemination (IUI), and other ART procedures have become mainstream options. Future developments are anticipated in areas such as personalized medicine, gene editing technologies, and improved success rates in ART procedures. The market is likely to see ongoing advancements, innovations, and collaborations aimed at addressing infertility challenges and expanding the range of options available to individuals and couples.
This report presents a comprehensive overview, market shares, and growth opportunities of Injectable IVF Medications market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
What is the 10-year outlook for the global Injectable IVF Medications market?
What factors are driving Injectable IVF Medications market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Injectable IVF Medications market opportunities vary by end market size?
How does Injectable IVF Medications break out type, application?
Injectable IVF (In Vitro Fertilization) medications are pharmaceutical drugs administered via injection to stimulate and regulate a woman's reproductive system during the fertility treatment process. These medications typically include hormones such as gonadotropins and follicle-stimulating hormone (FSH), which encourage the development of multiple eggs within the ovaries. Additionally, other drugs like human chorionic gonadotropin (hCG) are used to trigger the final maturation of eggs before retrieval. Injectable IVF medications play a crucial role in controlling the ovulation process, optimizing egg production, and enhancing the chances of successful fertilization during assisted reproductive technologies.
The global Injectable IVF Medications market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Injectable IVF Medications Industry Forecast” looks at past sales and reviews total world Injectable IVF Medications sales in 2023, providing a comprehensive analysis by region and market sector of projected Injectable IVF Medications sales for 2024 through 2030. With Injectable IVF Medications sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Injectable IVF Medications industry.
This Insight Report provides a comprehensive analysis of the global Injectable IVF Medications landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Injectable IVF Medications portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Injectable IVF Medications market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Injectable IVF Medications and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Injectable IVF Medications.
The fertility preservation and infertility treatment market has witnessed significant growth in recent years, driven by factors such as increasing infertility rates, delayed pregnancies, advancements in assisted reproductive technologies (ART), and growing awareness. Fertility preservation technologies, including egg freezing and sperm banking, have gained popularity among individuals seeking to preserve their reproductive potential. In the infertility treatment segment, in vitro fertilization (IVF), intrauterine insemination (IUI), and other ART procedures have become mainstream options. Future developments are anticipated in areas such as personalized medicine, gene editing technologies, and improved success rates in ART procedures. The market is likely to see ongoing advancements, innovations, and collaborations aimed at addressing infertility challenges and expanding the range of options available to individuals and couples.
This report presents a comprehensive overview, market shares, and growth opportunities of Injectable IVF Medications market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
- Follicle Stimulating Hormone (FSH)
- Luteinizing Hormone (LH)
- Human Chorionic Gonadotropin (hCG)
- Others
- IVF and Embryo Transfer
- Infertility Treatment
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Gonal-F (Merck)
- Follistim (Organon)
- Bravelle (Ferring)
- Menopur (Ferring)
- Fostimon (IBSA)
- Puregon (Organon)
- BEMFOLA (Gedeon Richter)
- Novarel (Ferring)
- Ovidrel (Merck)
- Synarel (Pfizer Medical)
- Follitrope (LG Chem)
- Profasi (Serum Institute Of India)
- Livzon
- GenSci
What is the 10-year outlook for the global Injectable IVF Medications market?
What factors are driving Injectable IVF Medications market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Injectable IVF Medications market opportunities vary by end market size?
How does Injectable IVF Medications break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Injectable IVF Medications Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Injectable IVF Medications by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Injectable IVF Medications by Country/Region, 2019, 2023 & 2030
2.2 Injectable IVF Medications Segment by Type
2.2.1 Follicle Stimulating Hormone (FSH)
2.2.2 Luteinizing Hormone (LH)
2.2.3 Human Chorionic Gonadotropin (hCG)
2.2.4 Others
2.3 Injectable IVF Medications Sales by Type
2.3.1 Global Injectable IVF Medications Sales Market Share by Type (2019-2024)
2.3.2 Global Injectable IVF Medications Revenue and Market Share by Type (2019-2024)
2.3.3 Global Injectable IVF Medications Sale Price by Type (2019-2024)
2.4 Injectable IVF Medications Segment by Application
2.4.1 IVF and Embryo Transfer
2.4.2 Infertility Treatment
2.5 Injectable IVF Medications Sales by Application
2.5.1 Global Injectable IVF Medications Sale Market Share by Application (2019-2024)
2.5.2 Global Injectable IVF Medications Revenue and Market Share by Application (2019-2024)
2.5.3 Global Injectable IVF Medications Sale Price by Application (2019-2024)
3 GLOBAL INJECTABLE IVF MEDICATIONS BY COMPANY
3.1 Global Injectable IVF Medications Breakdown Data by Company
3.1.1 Global Injectable IVF Medications Annual Sales by Company (2019-2024)
3.1.2 Global Injectable IVF Medications Sales Market Share by Company (2019-2024)
3.2 Global Injectable IVF Medications Annual Revenue by Company (2019-2024)
3.2.1 Global Injectable IVF Medications Revenue by Company (2019-2024)
3.2.2 Global Injectable IVF Medications Revenue Market Share by Company (2019-2024)
3.3 Global Injectable IVF Medications Sale Price by Company
3.4 Key Manufacturers Injectable IVF Medications Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Injectable IVF Medications Product Location Distribution
3.4.2 Players Injectable IVF Medications Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INJECTABLE IVF MEDICATIONS BY GEOGRAPHIC REGION
4.1 World Historic Injectable IVF Medications Market Size by Geographic Region (2019-2024)
4.1.1 Global Injectable IVF Medications Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Injectable IVF Medications Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Injectable IVF Medications Market Size by Country/Region (2019-2024)
4.2.1 Global Injectable IVF Medications Annual Sales by Country/Region (2019-2024)
4.2.2 Global Injectable IVF Medications Annual Revenue by Country/Region (2019-2024)
4.3 Americas Injectable IVF Medications Sales Growth
4.4 APAC Injectable IVF Medications Sales Growth
4.5 Europe Injectable IVF Medications Sales Growth
4.6 Middle East & Africa Injectable IVF Medications Sales Growth
5 AMERICAS
5.1 Americas Injectable IVF Medications Sales by Country
5.1.1 Americas Injectable IVF Medications Sales by Country (2019-2024)
5.1.2 Americas Injectable IVF Medications Revenue by Country (2019-2024)
5.2 Americas Injectable IVF Medications Sales by Type
5.3 Americas Injectable IVF Medications Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Injectable IVF Medications Sales by Region
6.1.1 APAC Injectable IVF Medications Sales by Region (2019-2024)
6.1.2 APAC Injectable IVF Medications Revenue by Region (2019-2024)
6.2 APAC Injectable IVF Medications Sales by Type
6.3 APAC Injectable IVF Medications Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Injectable IVF Medications by Country
7.1.1 Europe Injectable IVF Medications Sales by Country (2019-2024)
7.1.2 Europe Injectable IVF Medications Revenue by Country (2019-2024)
7.2 Europe Injectable IVF Medications Sales by Type
7.3 Europe Injectable IVF Medications Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Injectable IVF Medications by Country
8.1.1 Middle East & Africa Injectable IVF Medications Sales by Country (2019-2024)
8.1.2 Middle East & Africa Injectable IVF Medications Revenue by Country (2019-2024)
8.2 Middle East & Africa Injectable IVF Medications Sales by Type
8.3 Middle East & Africa Injectable IVF Medications Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Injectable IVF Medications
10.3 Manufacturing Process Analysis of Injectable IVF Medications
10.4 Industry Chain Structure of Injectable IVF Medications
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Injectable IVF Medications Distributors
11.3 Injectable IVF Medications Customer
12 WORLD FORECAST REVIEW FOR INJECTABLE IVF MEDICATIONS BY GEOGRAPHIC REGION
12.1 Global Injectable IVF Medications Market Size Forecast by Region
12.1.1 Global Injectable IVF Medications Forecast by Region (2025-2030)
12.1.2 Global Injectable IVF Medications Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Injectable IVF Medications Forecast by Type
12.7 Global Injectable IVF Medications Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Gonal-F (Merck)
13.1.1 Gonal-F (Merck) Company Information
13.1.2 Gonal-F (Merck) Injectable IVF Medications Product Portfolios and Specifications
13.1.3 Gonal-F (Merck) Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Gonal-F (Merck) Main Business Overview
13.1.5 Gonal-F (Merck) Latest Developments
13.2 Follistim (Organon)
13.2.1 Follistim (Organon) Company Information
13.2.2 Follistim (Organon) Injectable IVF Medications Product Portfolios and Specifications
13.2.3 Follistim (Organon) Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Follistim (Organon) Main Business Overview
13.2.5 Follistim (Organon) Latest Developments
13.3 Bravelle (Ferring)
13.3.1 Bravelle (Ferring) Company Information
13.3.2 Bravelle (Ferring) Injectable IVF Medications Product Portfolios and Specifications
13.3.3 Bravelle (Ferring) Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Bravelle (Ferring) Main Business Overview
13.3.5 Bravelle (Ferring) Latest Developments
13.4 Menopur (Ferring)
13.4.1 Menopur (Ferring) Company Information
13.4.2 Menopur (Ferring) Injectable IVF Medications Product Portfolios and Specifications
13.4.3 Menopur (Ferring) Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Menopur (Ferring) Main Business Overview
13.4.5 Menopur (Ferring) Latest Developments
13.5 Fostimon (IBSA)
13.5.1 Fostimon (IBSA) Company Information
13.5.2 Fostimon (IBSA) Injectable IVF Medications Product Portfolios and Specifications
13.5.3 Fostimon (IBSA) Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Fostimon (IBSA) Main Business Overview
13.5.5 Fostimon (IBSA) Latest Developments
13.6 Puregon (Organon)
13.6.1 Puregon (Organon) Company Information
13.6.2 Puregon (Organon) Injectable IVF Medications Product Portfolios and Specifications
13.6.3 Puregon (Organon) Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Puregon (Organon) Main Business Overview
13.6.5 Puregon (Organon) Latest Developments
13.7 BEMFOLA (Gedeon Richter)
13.7.1 BEMFOLA (Gedeon Richter) Company Information
13.7.2 BEMFOLA (Gedeon Richter) Injectable IVF Medications Product Portfolios and Specifications
13.7.3 BEMFOLA (Gedeon Richter) Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 BEMFOLA (Gedeon Richter) Main Business Overview
13.7.5 BEMFOLA (Gedeon Richter) Latest Developments
13.8 Novarel (Ferring)
13.8.1 Novarel (Ferring) Company Information
13.8.2 Novarel (Ferring) Injectable IVF Medications Product Portfolios and Specifications
13.8.3 Novarel (Ferring) Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Novarel (Ferring) Main Business Overview
13.8.5 Novarel (Ferring) Latest Developments
13.9 Ovidrel (Merck)
13.9.1 Ovidrel (Merck) Company Information
13.9.2 Ovidrel (Merck) Injectable IVF Medications Product Portfolios and Specifications
13.9.3 Ovidrel (Merck) Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Ovidrel (Merck) Main Business Overview
13.9.5 Ovidrel (Merck) Latest Developments
13.10 Synarel (Pfizer Medical)
13.10.1 Synarel (Pfizer Medical) Company Information
13.10.2 Synarel (Pfizer Medical) Injectable IVF Medications Product Portfolios and Specifications
13.10.3 Synarel (Pfizer Medical) Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Synarel (Pfizer Medical) Main Business Overview
13.10.5 Synarel (Pfizer Medical) Latest Developments
13.11 Follitrope (LG Chem)
13.11.1 Follitrope (LG Chem) Company Information
13.11.2 Follitrope (LG Chem) Injectable IVF Medications Product Portfolios and Specifications
13.11.3 Follitrope (LG Chem) Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Follitrope (LG Chem) Main Business Overview
13.11.5 Follitrope (LG Chem) Latest Developments
13.12 Profasi (Serum Institute Of India)
13.12.1 Profasi (Serum Institute Of India) Company Information
13.12.2 Profasi (Serum Institute Of India) Injectable IVF Medications Product Portfolios and Specifications
13.12.3 Profasi (Serum Institute Of India) Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Profasi (Serum Institute Of India) Main Business Overview
13.12.5 Profasi (Serum Institute Of India) Latest Developments
13.13 Livzon
13.13.1 Livzon Company Information
13.13.2 Livzon Injectable IVF Medications Product Portfolios and Specifications
13.13.3 Livzon Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Livzon Main Business Overview
13.13.5 Livzon Latest Developments
13.14 GenSci
13.14.1 GenSci Company Information
13.14.2 GenSci Injectable IVF Medications Product Portfolios and Specifications
13.14.3 GenSci Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 GenSci Main Business Overview
13.14.5 GenSci Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Injectable IVF Medications Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Injectable IVF Medications by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Injectable IVF Medications by Country/Region, 2019, 2023 & 2030
2.2 Injectable IVF Medications Segment by Type
2.2.1 Follicle Stimulating Hormone (FSH)
2.2.2 Luteinizing Hormone (LH)
2.2.3 Human Chorionic Gonadotropin (hCG)
2.2.4 Others
2.3 Injectable IVF Medications Sales by Type
2.3.1 Global Injectable IVF Medications Sales Market Share by Type (2019-2024)
2.3.2 Global Injectable IVF Medications Revenue and Market Share by Type (2019-2024)
2.3.3 Global Injectable IVF Medications Sale Price by Type (2019-2024)
2.4 Injectable IVF Medications Segment by Application
2.4.1 IVF and Embryo Transfer
2.4.2 Infertility Treatment
2.5 Injectable IVF Medications Sales by Application
2.5.1 Global Injectable IVF Medications Sale Market Share by Application (2019-2024)
2.5.2 Global Injectable IVF Medications Revenue and Market Share by Application (2019-2024)
2.5.3 Global Injectable IVF Medications Sale Price by Application (2019-2024)
3 GLOBAL INJECTABLE IVF MEDICATIONS BY COMPANY
3.1 Global Injectable IVF Medications Breakdown Data by Company
3.1.1 Global Injectable IVF Medications Annual Sales by Company (2019-2024)
3.1.2 Global Injectable IVF Medications Sales Market Share by Company (2019-2024)
3.2 Global Injectable IVF Medications Annual Revenue by Company (2019-2024)
3.2.1 Global Injectable IVF Medications Revenue by Company (2019-2024)
3.2.2 Global Injectable IVF Medications Revenue Market Share by Company (2019-2024)
3.3 Global Injectable IVF Medications Sale Price by Company
3.4 Key Manufacturers Injectable IVF Medications Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Injectable IVF Medications Product Location Distribution
3.4.2 Players Injectable IVF Medications Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INJECTABLE IVF MEDICATIONS BY GEOGRAPHIC REGION
4.1 World Historic Injectable IVF Medications Market Size by Geographic Region (2019-2024)
4.1.1 Global Injectable IVF Medications Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Injectable IVF Medications Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Injectable IVF Medications Market Size by Country/Region (2019-2024)
4.2.1 Global Injectable IVF Medications Annual Sales by Country/Region (2019-2024)
4.2.2 Global Injectable IVF Medications Annual Revenue by Country/Region (2019-2024)
4.3 Americas Injectable IVF Medications Sales Growth
4.4 APAC Injectable IVF Medications Sales Growth
4.5 Europe Injectable IVF Medications Sales Growth
4.6 Middle East & Africa Injectable IVF Medications Sales Growth
5 AMERICAS
5.1 Americas Injectable IVF Medications Sales by Country
5.1.1 Americas Injectable IVF Medications Sales by Country (2019-2024)
5.1.2 Americas Injectable IVF Medications Revenue by Country (2019-2024)
5.2 Americas Injectable IVF Medications Sales by Type
5.3 Americas Injectable IVF Medications Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Injectable IVF Medications Sales by Region
6.1.1 APAC Injectable IVF Medications Sales by Region (2019-2024)
6.1.2 APAC Injectable IVF Medications Revenue by Region (2019-2024)
6.2 APAC Injectable IVF Medications Sales by Type
6.3 APAC Injectable IVF Medications Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Injectable IVF Medications by Country
7.1.1 Europe Injectable IVF Medications Sales by Country (2019-2024)
7.1.2 Europe Injectable IVF Medications Revenue by Country (2019-2024)
7.2 Europe Injectable IVF Medications Sales by Type
7.3 Europe Injectable IVF Medications Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Injectable IVF Medications by Country
8.1.1 Middle East & Africa Injectable IVF Medications Sales by Country (2019-2024)
8.1.2 Middle East & Africa Injectable IVF Medications Revenue by Country (2019-2024)
8.2 Middle East & Africa Injectable IVF Medications Sales by Type
8.3 Middle East & Africa Injectable IVF Medications Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Injectable IVF Medications
10.3 Manufacturing Process Analysis of Injectable IVF Medications
10.4 Industry Chain Structure of Injectable IVF Medications
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Injectable IVF Medications Distributors
11.3 Injectable IVF Medications Customer
12 WORLD FORECAST REVIEW FOR INJECTABLE IVF MEDICATIONS BY GEOGRAPHIC REGION
12.1 Global Injectable IVF Medications Market Size Forecast by Region
12.1.1 Global Injectable IVF Medications Forecast by Region (2025-2030)
12.1.2 Global Injectable IVF Medications Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Injectable IVF Medications Forecast by Type
12.7 Global Injectable IVF Medications Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Gonal-F (Merck)
13.1.1 Gonal-F (Merck) Company Information
13.1.2 Gonal-F (Merck) Injectable IVF Medications Product Portfolios and Specifications
13.1.3 Gonal-F (Merck) Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Gonal-F (Merck) Main Business Overview
13.1.5 Gonal-F (Merck) Latest Developments
13.2 Follistim (Organon)
13.2.1 Follistim (Organon) Company Information
13.2.2 Follistim (Organon) Injectable IVF Medications Product Portfolios and Specifications
13.2.3 Follistim (Organon) Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Follistim (Organon) Main Business Overview
13.2.5 Follistim (Organon) Latest Developments
13.3 Bravelle (Ferring)
13.3.1 Bravelle (Ferring) Company Information
13.3.2 Bravelle (Ferring) Injectable IVF Medications Product Portfolios and Specifications
13.3.3 Bravelle (Ferring) Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Bravelle (Ferring) Main Business Overview
13.3.5 Bravelle (Ferring) Latest Developments
13.4 Menopur (Ferring)
13.4.1 Menopur (Ferring) Company Information
13.4.2 Menopur (Ferring) Injectable IVF Medications Product Portfolios and Specifications
13.4.3 Menopur (Ferring) Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Menopur (Ferring) Main Business Overview
13.4.5 Menopur (Ferring) Latest Developments
13.5 Fostimon (IBSA)
13.5.1 Fostimon (IBSA) Company Information
13.5.2 Fostimon (IBSA) Injectable IVF Medications Product Portfolios and Specifications
13.5.3 Fostimon (IBSA) Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Fostimon (IBSA) Main Business Overview
13.5.5 Fostimon (IBSA) Latest Developments
13.6 Puregon (Organon)
13.6.1 Puregon (Organon) Company Information
13.6.2 Puregon (Organon) Injectable IVF Medications Product Portfolios and Specifications
13.6.3 Puregon (Organon) Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Puregon (Organon) Main Business Overview
13.6.5 Puregon (Organon) Latest Developments
13.7 BEMFOLA (Gedeon Richter)
13.7.1 BEMFOLA (Gedeon Richter) Company Information
13.7.2 BEMFOLA (Gedeon Richter) Injectable IVF Medications Product Portfolios and Specifications
13.7.3 BEMFOLA (Gedeon Richter) Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 BEMFOLA (Gedeon Richter) Main Business Overview
13.7.5 BEMFOLA (Gedeon Richter) Latest Developments
13.8 Novarel (Ferring)
13.8.1 Novarel (Ferring) Company Information
13.8.2 Novarel (Ferring) Injectable IVF Medications Product Portfolios and Specifications
13.8.3 Novarel (Ferring) Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Novarel (Ferring) Main Business Overview
13.8.5 Novarel (Ferring) Latest Developments
13.9 Ovidrel (Merck)
13.9.1 Ovidrel (Merck) Company Information
13.9.2 Ovidrel (Merck) Injectable IVF Medications Product Portfolios and Specifications
13.9.3 Ovidrel (Merck) Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Ovidrel (Merck) Main Business Overview
13.9.5 Ovidrel (Merck) Latest Developments
13.10 Synarel (Pfizer Medical)
13.10.1 Synarel (Pfizer Medical) Company Information
13.10.2 Synarel (Pfizer Medical) Injectable IVF Medications Product Portfolios and Specifications
13.10.3 Synarel (Pfizer Medical) Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Synarel (Pfizer Medical) Main Business Overview
13.10.5 Synarel (Pfizer Medical) Latest Developments
13.11 Follitrope (LG Chem)
13.11.1 Follitrope (LG Chem) Company Information
13.11.2 Follitrope (LG Chem) Injectable IVF Medications Product Portfolios and Specifications
13.11.3 Follitrope (LG Chem) Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Follitrope (LG Chem) Main Business Overview
13.11.5 Follitrope (LG Chem) Latest Developments
13.12 Profasi (Serum Institute Of India)
13.12.1 Profasi (Serum Institute Of India) Company Information
13.12.2 Profasi (Serum Institute Of India) Injectable IVF Medications Product Portfolios and Specifications
13.12.3 Profasi (Serum Institute Of India) Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Profasi (Serum Institute Of India) Main Business Overview
13.12.5 Profasi (Serum Institute Of India) Latest Developments
13.13 Livzon
13.13.1 Livzon Company Information
13.13.2 Livzon Injectable IVF Medications Product Portfolios and Specifications
13.13.3 Livzon Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Livzon Main Business Overview
13.13.5 Livzon Latest Developments
13.14 GenSci
13.14.1 GenSci Company Information
13.14.2 GenSci Injectable IVF Medications Product Portfolios and Specifications
13.14.3 GenSci Injectable IVF Medications Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 GenSci Main Business Overview
13.14.5 GenSci Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Injectable IVF Medications Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Injectable IVF Medications Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Follicle Stimulating Hormone (FSH)
Table 4. Major Players of Luteinizing Hormone (LH)
Table 5. Major Players of Human Chorionic Gonadotropin (hCG)
Table 6. Major Players of Others
Table 7. Global Injectable IVF Medications Sales by Type (2019-2024) & (K Units)
Table 8. Global Injectable IVF Medications Sales Market Share by Type (2019-2024)
Table 9. Global Injectable IVF Medications Revenue by Type (2019-2024) & ($ million)
Table 10. Global Injectable IVF Medications Revenue Market Share by Type (2019-2024)
Table 11. Global Injectable IVF Medications Sale Price by Type (2019-2024) & (US$/Unit)
Table 12. Global Injectable IVF Medications Sales by Application (2019-2024) & (K Units)
Table 13. Global Injectable IVF Medications Sales Market Share by Application (2019-2024)
Table 14. Global Injectable IVF Medications Revenue by Application (2019-2024)
Table 15. Global Injectable IVF Medications Revenue Market Share by Application (2019-2024)
Table 16. Global Injectable IVF Medications Sale Price by Application (2019-2024) & (US$/Unit)
Table 17. Global Injectable IVF Medications Sales by Company (2019-2024) & (K Units)
Table 18. Global Injectable IVF Medications Sales Market Share by Company (2019-2024)
Table 19. Global Injectable IVF Medications Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Injectable IVF Medications Revenue Market Share by Company (2019-2024)
Table 21. Global Injectable IVF Medications Sale Price by Company (2019-2024) & (US$/Unit)
Table 22. Key Manufacturers Injectable IVF Medications Producing Area Distribution and Sales Area
Table 23. Players Injectable IVF Medications Products Offered
Table 24. Injectable IVF Medications Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Injectable IVF Medications Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Injectable IVF Medications Sales Market Share Geographic Region (2019-2024)
Table 29. Global Injectable IVF Medications Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Injectable IVF Medications Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Injectable IVF Medications Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Injectable IVF Medications Sales Market Share by Country/Region (2019-2024)
Table 33. Global Injectable IVF Medications Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Injectable IVF Medications Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Injectable IVF Medications Sales by Country (2019-2024) & (K Units)
Table 36. Americas Injectable IVF Medications Sales Market Share by Country (2019-2024)
Table 37. Americas Injectable IVF Medications Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Injectable IVF Medications Revenue Market Share by Country (2019-2024)
Table 39. Americas Injectable IVF Medications Sales by Type (2019-2024) & (K Units)
Table 40. Americas Injectable IVF Medications Sales by Application (2019-2024) & (K Units)
Table 41. APAC Injectable IVF Medications Sales by Region (2019-2024) & (K Units)
Table 42. APAC Injectable IVF Medications Sales Market Share by Region (2019-2024)
Table 43. APAC Injectable IVF Medications Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Injectable IVF Medications Revenue Market Share by Region (2019-2024)
Table 45. APAC Injectable IVF Medications Sales by Type (2019-2024) & (K Units)
Table 46. APAC Injectable IVF Medications Sales by Application (2019-2024) & (K Units)
Table 47. Europe Injectable IVF Medications Sales by Country (2019-2024) & (K Units)
Table 48. Europe Injectable IVF Medications Sales Market Share by Country (2019-2024)
Table 49. Europe Injectable IVF Medications Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Injectable IVF Medications Revenue Market Share by Country (2019-2024)
Table 51. Europe Injectable IVF Medications Sales by Type (2019-2024) & (K Units)
Table 52. Europe Injectable IVF Medications Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Injectable IVF Medications Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Injectable IVF Medications Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Injectable IVF Medications Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Injectable IVF Medications Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Injectable IVF Medications Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Injectable IVF Medications Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Injectable IVF Medications
Table 60. Key Market Challenges & Risks of Injectable IVF Medications
Table 61. Key Industry Trends of Injectable IVF Medications
Table 62. Injectable IVF Medications Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Injectable IVF Medications Distributors List
Table 65. Injectable IVF Medications Customer List
Table 66. Global Injectable IVF Medications Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Injectable IVF Medications Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Injectable IVF Medications Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Injectable IVF Medications Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Injectable IVF Medications Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Injectable IVF Medications Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Injectable IVF Medications Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Injectable IVF Medications Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Injectable IVF Medications Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Injectable IVF Medications Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Injectable IVF Medications Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Injectable IVF Medications Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Injectable IVF Medications Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Injectable IVF Medications Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Gonal-F (Merck) Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 81. Gonal-F (Merck) Injectable IVF Medications Product Portfolios and Specifications
Table 82. Gonal-F (Merck) Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Gonal-F (Merck) Main Business
Table 84. Gonal-F (Merck) Latest Developments
Table 85. Follistim (Organon) Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 86. Follistim (Organon) Injectable IVF Medications Product Portfolios and Specifications
Table 87. Follistim (Organon) Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Follistim (Organon) Main Business
Table 89. Follistim (Organon) Latest Developments
Table 90. Bravelle (Ferring) Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 91. Bravelle (Ferring) Injectable IVF Medications Product Portfolios and Specifications
Table 92. Bravelle (Ferring) Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Bravelle (Ferring) Main Business
Table 94. Bravelle (Ferring) Latest Developments
Table 95. Menopur (Ferring) Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 96. Menopur (Ferring) Injectable IVF Medications Product Portfolios and Specifications
Table 97. Menopur (Ferring) Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Menopur (Ferring) Main Business
Table 99. Menopur (Ferring) Latest Developments
Table 100. Fostimon (IBSA) Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 101. Fostimon (IBSA) Injectable IVF Medications Product Portfolios and Specifications
Table 102. Fostimon (IBSA) Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Fostimon (IBSA) Main Business
Table 104. Fostimon (IBSA) Latest Developments
Table 105. Puregon (Organon) Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 106. Puregon (Organon) Injectable IVF Medications Product Portfolios and Specifications
Table 107. Puregon (Organon) Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Puregon (Organon) Main Business
Table 109. Puregon (Organon) Latest Developments
Table 110. BEMFOLA (Gedeon Richter) Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 111. BEMFOLA (Gedeon Richter) Injectable IVF Medications Product Portfolios and Specifications
Table 112. BEMFOLA (Gedeon Richter) Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. BEMFOLA (Gedeon Richter) Main Business
Table 114. BEMFOLA (Gedeon Richter) Latest Developments
Table 115. Novarel (Ferring) Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 116. Novarel (Ferring) Injectable IVF Medications Product Portfolios and Specifications
Table 117. Novarel (Ferring) Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Novarel (Ferring) Main Business
Table 119. Novarel (Ferring) Latest Developments
Table 120. Ovidrel (Merck) Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 121. Ovidrel (Merck) Injectable IVF Medications Product Portfolios and Specifications
Table 122. Ovidrel (Merck) Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Ovidrel (Merck) Main Business
Table 124. Ovidrel (Merck) Latest Developments
Table 125. Synarel (Pfizer Medical) Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 126. Synarel (Pfizer Medical) Injectable IVF Medications Product Portfolios and Specifications
Table 127. Synarel (Pfizer Medical) Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Synarel (Pfizer Medical) Main Business
Table 129. Synarel (Pfizer Medical) Latest Developments
Table 130. Follitrope (LG Chem) Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 131. Follitrope (LG Chem) Injectable IVF Medications Product Portfolios and Specifications
Table 132. Follitrope (LG Chem) Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Follitrope (LG Chem) Main Business
Table 134. Follitrope (LG Chem) Latest Developments
Table 135. Profasi (Serum Institute Of India) Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 136. Profasi (Serum Institute Of India) Injectable IVF Medications Product Portfolios and Specifications
Table 137. Profasi (Serum Institute Of India) Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Profasi (Serum Institute Of India) Main Business
Table 139. Profasi (Serum Institute Of India) Latest Developments
Table 140. Livzon Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 141. Livzon Injectable IVF Medications Product Portfolios and Specifications
Table 142. Livzon Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Livzon Main Business
Table 144. Livzon Latest Developments
Table 145. GenSci Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 146. GenSci Injectable IVF Medications Product Portfolios and Specifications
Table 147. GenSci Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. GenSci Main Business
Table 149. GenSci Latest Developments
Table 1. Injectable IVF Medications Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Injectable IVF Medications Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Follicle Stimulating Hormone (FSH)
Table 4. Major Players of Luteinizing Hormone (LH)
Table 5. Major Players of Human Chorionic Gonadotropin (hCG)
Table 6. Major Players of Others
Table 7. Global Injectable IVF Medications Sales by Type (2019-2024) & (K Units)
Table 8. Global Injectable IVF Medications Sales Market Share by Type (2019-2024)
Table 9. Global Injectable IVF Medications Revenue by Type (2019-2024) & ($ million)
Table 10. Global Injectable IVF Medications Revenue Market Share by Type (2019-2024)
Table 11. Global Injectable IVF Medications Sale Price by Type (2019-2024) & (US$/Unit)
Table 12. Global Injectable IVF Medications Sales by Application (2019-2024) & (K Units)
Table 13. Global Injectable IVF Medications Sales Market Share by Application (2019-2024)
Table 14. Global Injectable IVF Medications Revenue by Application (2019-2024)
Table 15. Global Injectable IVF Medications Revenue Market Share by Application (2019-2024)
Table 16. Global Injectable IVF Medications Sale Price by Application (2019-2024) & (US$/Unit)
Table 17. Global Injectable IVF Medications Sales by Company (2019-2024) & (K Units)
Table 18. Global Injectable IVF Medications Sales Market Share by Company (2019-2024)
Table 19. Global Injectable IVF Medications Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Injectable IVF Medications Revenue Market Share by Company (2019-2024)
Table 21. Global Injectable IVF Medications Sale Price by Company (2019-2024) & (US$/Unit)
Table 22. Key Manufacturers Injectable IVF Medications Producing Area Distribution and Sales Area
Table 23. Players Injectable IVF Medications Products Offered
Table 24. Injectable IVF Medications Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Injectable IVF Medications Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Injectable IVF Medications Sales Market Share Geographic Region (2019-2024)
Table 29. Global Injectable IVF Medications Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Injectable IVF Medications Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Injectable IVF Medications Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Injectable IVF Medications Sales Market Share by Country/Region (2019-2024)
Table 33. Global Injectable IVF Medications Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Injectable IVF Medications Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Injectable IVF Medications Sales by Country (2019-2024) & (K Units)
Table 36. Americas Injectable IVF Medications Sales Market Share by Country (2019-2024)
Table 37. Americas Injectable IVF Medications Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Injectable IVF Medications Revenue Market Share by Country (2019-2024)
Table 39. Americas Injectable IVF Medications Sales by Type (2019-2024) & (K Units)
Table 40. Americas Injectable IVF Medications Sales by Application (2019-2024) & (K Units)
Table 41. APAC Injectable IVF Medications Sales by Region (2019-2024) & (K Units)
Table 42. APAC Injectable IVF Medications Sales Market Share by Region (2019-2024)
Table 43. APAC Injectable IVF Medications Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Injectable IVF Medications Revenue Market Share by Region (2019-2024)
Table 45. APAC Injectable IVF Medications Sales by Type (2019-2024) & (K Units)
Table 46. APAC Injectable IVF Medications Sales by Application (2019-2024) & (K Units)
Table 47. Europe Injectable IVF Medications Sales by Country (2019-2024) & (K Units)
Table 48. Europe Injectable IVF Medications Sales Market Share by Country (2019-2024)
Table 49. Europe Injectable IVF Medications Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Injectable IVF Medications Revenue Market Share by Country (2019-2024)
Table 51. Europe Injectable IVF Medications Sales by Type (2019-2024) & (K Units)
Table 52. Europe Injectable IVF Medications Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Injectable IVF Medications Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Injectable IVF Medications Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Injectable IVF Medications Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Injectable IVF Medications Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Injectable IVF Medications Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Injectable IVF Medications Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Injectable IVF Medications
Table 60. Key Market Challenges & Risks of Injectable IVF Medications
Table 61. Key Industry Trends of Injectable IVF Medications
Table 62. Injectable IVF Medications Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Injectable IVF Medications Distributors List
Table 65. Injectable IVF Medications Customer List
Table 66. Global Injectable IVF Medications Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Injectable IVF Medications Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Injectable IVF Medications Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Injectable IVF Medications Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Injectable IVF Medications Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Injectable IVF Medications Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Injectable IVF Medications Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Injectable IVF Medications Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Injectable IVF Medications Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Injectable IVF Medications Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Injectable IVF Medications Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Injectable IVF Medications Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Injectable IVF Medications Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Injectable IVF Medications Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Gonal-F (Merck) Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 81. Gonal-F (Merck) Injectable IVF Medications Product Portfolios and Specifications
Table 82. Gonal-F (Merck) Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Gonal-F (Merck) Main Business
Table 84. Gonal-F (Merck) Latest Developments
Table 85. Follistim (Organon) Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 86. Follistim (Organon) Injectable IVF Medications Product Portfolios and Specifications
Table 87. Follistim (Organon) Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Follistim (Organon) Main Business
Table 89. Follistim (Organon) Latest Developments
Table 90. Bravelle (Ferring) Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 91. Bravelle (Ferring) Injectable IVF Medications Product Portfolios and Specifications
Table 92. Bravelle (Ferring) Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Bravelle (Ferring) Main Business
Table 94. Bravelle (Ferring) Latest Developments
Table 95. Menopur (Ferring) Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 96. Menopur (Ferring) Injectable IVF Medications Product Portfolios and Specifications
Table 97. Menopur (Ferring) Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Menopur (Ferring) Main Business
Table 99. Menopur (Ferring) Latest Developments
Table 100. Fostimon (IBSA) Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 101. Fostimon (IBSA) Injectable IVF Medications Product Portfolios and Specifications
Table 102. Fostimon (IBSA) Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Fostimon (IBSA) Main Business
Table 104. Fostimon (IBSA) Latest Developments
Table 105. Puregon (Organon) Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 106. Puregon (Organon) Injectable IVF Medications Product Portfolios and Specifications
Table 107. Puregon (Organon) Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Puregon (Organon) Main Business
Table 109. Puregon (Organon) Latest Developments
Table 110. BEMFOLA (Gedeon Richter) Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 111. BEMFOLA (Gedeon Richter) Injectable IVF Medications Product Portfolios and Specifications
Table 112. BEMFOLA (Gedeon Richter) Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. BEMFOLA (Gedeon Richter) Main Business
Table 114. BEMFOLA (Gedeon Richter) Latest Developments
Table 115. Novarel (Ferring) Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 116. Novarel (Ferring) Injectable IVF Medications Product Portfolios and Specifications
Table 117. Novarel (Ferring) Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Novarel (Ferring) Main Business
Table 119. Novarel (Ferring) Latest Developments
Table 120. Ovidrel (Merck) Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 121. Ovidrel (Merck) Injectable IVF Medications Product Portfolios and Specifications
Table 122. Ovidrel (Merck) Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Ovidrel (Merck) Main Business
Table 124. Ovidrel (Merck) Latest Developments
Table 125. Synarel (Pfizer Medical) Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 126. Synarel (Pfizer Medical) Injectable IVF Medications Product Portfolios and Specifications
Table 127. Synarel (Pfizer Medical) Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Synarel (Pfizer Medical) Main Business
Table 129. Synarel (Pfizer Medical) Latest Developments
Table 130. Follitrope (LG Chem) Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 131. Follitrope (LG Chem) Injectable IVF Medications Product Portfolios and Specifications
Table 132. Follitrope (LG Chem) Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Follitrope (LG Chem) Main Business
Table 134. Follitrope (LG Chem) Latest Developments
Table 135. Profasi (Serum Institute Of India) Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 136. Profasi (Serum Institute Of India) Injectable IVF Medications Product Portfolios and Specifications
Table 137. Profasi (Serum Institute Of India) Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Profasi (Serum Institute Of India) Main Business
Table 139. Profasi (Serum Institute Of India) Latest Developments
Table 140. Livzon Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 141. Livzon Injectable IVF Medications Product Portfolios and Specifications
Table 142. Livzon Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Livzon Main Business
Table 144. Livzon Latest Developments
Table 145. GenSci Basic Information, Injectable IVF Medications Manufacturing Base, Sales Area and Its Competitors
Table 146. GenSci Injectable IVF Medications Product Portfolios and Specifications
Table 147. GenSci Injectable IVF Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. GenSci Main Business
Table 149. GenSci Latest Developments
LIST OF FIGURES
Figure 1. Picture of Injectable IVF Medications
Figure 2. Injectable IVF Medications Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Injectable IVF Medications Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Injectable IVF Medications Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Injectable IVF Medications Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Follicle Stimulating Hormone (FSH)
Figure 10. Product Picture of Luteinizing Hormone (LH)
Figure 11. Product Picture of Human Chorionic Gonadotropin (hCG)
Figure 12. Product Picture of Others
Figure 13. Global Injectable IVF Medications Sales Market Share by Type in 2023
Figure 14. Global Injectable IVF Medications Revenue Market Share by Type (2019-2024)
Figure 15. Injectable IVF Medications Consumed in IVF and Embryo Transfer
Figure 16. Global Injectable IVF Medications Market: IVF and Embryo Transfer (2019-2024) & (K Units)
Figure 17. Injectable IVF Medications Consumed in Infertility Treatment
Figure 18. Global Injectable IVF Medications Market: Infertility Treatment (2019-2024) & (K Units)
Figure 19. Global Injectable IVF Medications Sales Market Share by Application (2023)
Figure 20. Global Injectable IVF Medications Revenue Market Share by Application in 2023
Figure 21. Injectable IVF Medications Sales Market by Company in 2023 (K Units)
Figure 22. Global Injectable IVF Medications Sales Market Share by Company in 2023
Figure 23. Injectable IVF Medications Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Injectable IVF Medications Revenue Market Share by Company in 2023
Figure 25. Global Injectable IVF Medications Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Injectable IVF Medications Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Injectable IVF Medications Sales 2019-2024 (K Units)
Figure 28. Americas Injectable IVF Medications Revenue 2019-2024 ($ Millions)
Figure 29. APAC Injectable IVF Medications Sales 2019-2024 (K Units)
Figure 30. APAC Injectable IVF Medications Revenue 2019-2024 ($ Millions)
Figure 31. Europe Injectable IVF Medications Sales 2019-2024 (K Units)
Figure 32. Europe Injectable IVF Medications Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Injectable IVF Medications Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Injectable IVF Medications Revenue 2019-2024 ($ Millions)
Figure 35. Americas Injectable IVF Medications Sales Market Share by Country in 2023
Figure 36. Americas Injectable IVF Medications Revenue Market Share by Country in 2023
Figure 37. Americas Injectable IVF Medications Sales Market Share by Type (2019-2024)
Figure 38. Americas Injectable IVF Medications Sales Market Share by Application (2019-2024)
Figure 39. United States Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Injectable IVF Medications Sales Market Share by Region in 2023
Figure 44. APAC Injectable IVF Medications Revenue Market Share by Regions in 2023
Figure 45. APAC Injectable IVF Medications Sales Market Share by Type (2019-2024)
Figure 46. APAC Injectable IVF Medications Sales Market Share by Application (2019-2024)
Figure 47. China Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Injectable IVF Medications Sales Market Share by Country in 2023
Figure 55. Europe Injectable IVF Medications Revenue Market Share by Country in 2023
Figure 56. Europe Injectable IVF Medications Sales Market Share by Type (2019-2024)
Figure 57. Europe Injectable IVF Medications Sales Market Share by Application (2019-2024)
Figure 58. Germany Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Injectable IVF Medications Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Injectable IVF Medications Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Injectable IVF Medications Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Injectable IVF Medications Sales Market Share by Application (2019-2024)
Figure 67. Egypt Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Injectable IVF Medications in 2023
Figure 73. Manufacturing Process Analysis of Injectable IVF Medications
Figure 74. Industry Chain Structure of Injectable IVF Medications
Figure 75. Channels of Distribution
Figure 76. Global Injectable IVF Medications Sales Market Forecast by Region (2025-2030)
Figure 77. Global Injectable IVF Medications Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Injectable IVF Medications Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Injectable IVF Medications Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Injectable IVF Medications Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Injectable IVF Medications Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Injectable IVF Medications
Figure 2. Injectable IVF Medications Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Injectable IVF Medications Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Injectable IVF Medications Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Injectable IVF Medications Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Follicle Stimulating Hormone (FSH)
Figure 10. Product Picture of Luteinizing Hormone (LH)
Figure 11. Product Picture of Human Chorionic Gonadotropin (hCG)
Figure 12. Product Picture of Others
Figure 13. Global Injectable IVF Medications Sales Market Share by Type in 2023
Figure 14. Global Injectable IVF Medications Revenue Market Share by Type (2019-2024)
Figure 15. Injectable IVF Medications Consumed in IVF and Embryo Transfer
Figure 16. Global Injectable IVF Medications Market: IVF and Embryo Transfer (2019-2024) & (K Units)
Figure 17. Injectable IVF Medications Consumed in Infertility Treatment
Figure 18. Global Injectable IVF Medications Market: Infertility Treatment (2019-2024) & (K Units)
Figure 19. Global Injectable IVF Medications Sales Market Share by Application (2023)
Figure 20. Global Injectable IVF Medications Revenue Market Share by Application in 2023
Figure 21. Injectable IVF Medications Sales Market by Company in 2023 (K Units)
Figure 22. Global Injectable IVF Medications Sales Market Share by Company in 2023
Figure 23. Injectable IVF Medications Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Injectable IVF Medications Revenue Market Share by Company in 2023
Figure 25. Global Injectable IVF Medications Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Injectable IVF Medications Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Injectable IVF Medications Sales 2019-2024 (K Units)
Figure 28. Americas Injectable IVF Medications Revenue 2019-2024 ($ Millions)
Figure 29. APAC Injectable IVF Medications Sales 2019-2024 (K Units)
Figure 30. APAC Injectable IVF Medications Revenue 2019-2024 ($ Millions)
Figure 31. Europe Injectable IVF Medications Sales 2019-2024 (K Units)
Figure 32. Europe Injectable IVF Medications Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Injectable IVF Medications Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Injectable IVF Medications Revenue 2019-2024 ($ Millions)
Figure 35. Americas Injectable IVF Medications Sales Market Share by Country in 2023
Figure 36. Americas Injectable IVF Medications Revenue Market Share by Country in 2023
Figure 37. Americas Injectable IVF Medications Sales Market Share by Type (2019-2024)
Figure 38. Americas Injectable IVF Medications Sales Market Share by Application (2019-2024)
Figure 39. United States Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Injectable IVF Medications Sales Market Share by Region in 2023
Figure 44. APAC Injectable IVF Medications Revenue Market Share by Regions in 2023
Figure 45. APAC Injectable IVF Medications Sales Market Share by Type (2019-2024)
Figure 46. APAC Injectable IVF Medications Sales Market Share by Application (2019-2024)
Figure 47. China Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Injectable IVF Medications Sales Market Share by Country in 2023
Figure 55. Europe Injectable IVF Medications Revenue Market Share by Country in 2023
Figure 56. Europe Injectable IVF Medications Sales Market Share by Type (2019-2024)
Figure 57. Europe Injectable IVF Medications Sales Market Share by Application (2019-2024)
Figure 58. Germany Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Injectable IVF Medications Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Injectable IVF Medications Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Injectable IVF Medications Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Injectable IVF Medications Sales Market Share by Application (2019-2024)
Figure 67. Egypt Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Injectable IVF Medications Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Injectable IVF Medications in 2023
Figure 73. Manufacturing Process Analysis of Injectable IVF Medications
Figure 74. Industry Chain Structure of Injectable IVF Medications
Figure 75. Channels of Distribution
Figure 76. Global Injectable IVF Medications Sales Market Forecast by Region (2025-2030)
Figure 77. Global Injectable IVF Medications Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Injectable IVF Medications Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Injectable IVF Medications Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Injectable IVF Medications Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Injectable IVF Medications Revenue Market Share Forecast by Application (2025-2030)
